{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["2f153a96-e28d-41ea-a6c0-679cf5b5912f", "Q2", 16987, "GRIZZLE COMPANY", 122646, "UNIVERSITY OF LOUISVILLE", 2016, "second_quarter", "2016-07-15T13:54:46.460000-04:00", 30000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/2f153a96-e28d-41ea-a6c0-679cf5b5912f/\", \"filing_uuid\": \"2f153a96-e28d-41ea-a6c0-679cf5b5912f\", \"filing_type\": \"Q2\", \"filing_type_display\": \"2nd Quarter - Report\", \"filing_year\": 2016, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/2f153a96-e28d-41ea-a6c0-679cf5b5912f/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"30000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"RICHARD A. CANTOR\", \"dt_posted\": \"2016-07-15T13:54:46.460000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1701 Pennsylvania Ave NW\", \"registrant_address_2\": \"Suite 300\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20006\", \"registrant\": {\"id\": 16987, \"url\": \"https://lda.senate.gov/api/v1/registrants/16987/\", \"house_registrant_id\": 31352, \"name\": \"GRIZZLE COMPANY\", \"description\": \"Government affairs consulting firm.\", \"address_1\": \"1701 Pennsylvania Ave NW\", \"address_2\": \"Suite 300\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20006\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"RICHARD A. CANTOR\", \"contact_telephone\": \"+1 202-234-2101\", \"dt_updated\": \"2022-04-06T16:06:09.638515-04:00\"}, \"client\": {\"id\": 122646, \"url\": \"https://lda.senate.gov/api/v1/clients/122646/\", \"client_id\": 137, \"name\": \"UNIVERSITY OF LOUISVILLE\", \"general_description\": null, \"client_government_entity\": true, \"client_self_select\": null, \"state\": \"KY\", \"state_display\": \"Kentucky\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"KY\", \"ppb_state_display\": \"Kentucky\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-07\"}, \"lobbying_activities\": [{\"general_issue_code\": \"TRA\", \"general_issue_code_display\": \"Transportation\", \"description\": \"Request letters of support for University Transportation Center grant proposals.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 19678, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"RICHARD\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"CANTOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CPT\", \"general_issue_code_display\": \"Copyright/Patent/Trademark\", \"description\": \"HR 9 \\\"The Innnovation Act\\\" and S. 1137 \\\"PATENT Act\\\" Oppose provisions harmful to research universities. \\nSupport for HR 2045, the TROL Act.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 19678, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"RICHARD\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"CANTOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 10442, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHARLES\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"GRIZZLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"ECN\", \"general_issue_code_display\": \"Economics/Economic Development\", \"description\": \"Reqeust letters of support for EDA grant proposals.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 19678, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"RICHARD\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"CANTOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Funding for Zika virus research.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 19678, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"RICHARD\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"CANTOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 10442, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHARLES\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"GRIZZLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"ENG\", \"general_issue_code_display\": \"Energy/Nuclear\", \"description\": \"Biomass fuel production for electric generation.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10442, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHARLES\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"GRIZZLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 19678, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"RICHARD\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"CANTOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"HR 5549 The Medical Marijuana Research Act.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10442, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHARLES\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"GRIZZLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["2f153a96-e28d-41ea-a6c0-679cf5b5912f"], "units": {}, "query_ms": 2.85706901922822, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}